News Pharmaceutical & Biotech Stories

COVID-19 Vaccine Likely to be Ready by October — Pfizer

Pfizer believes that a COVID-19 vaccine could be ready by the end of October 2020.

The race for finding an effective vaccine against COVID-19 is getting intense with each passing day. More than 100 potential vaccines are being tested in different laboratories across the globe to combat the novel coronavirus.

American drug maker company Pfizer has claimed the COVID-19 vaccine could be available by the end of October, said Pfizer CEO Albert Bourla.

“If things go well, and the stars are aligned, we will have enough evidence of safety and efficacy so that we can… have a vaccine around the end of October,” Bourla was quoted as saying in the report, CNBC-TV18 said.

Pfizer is conducting clinical trials in the US and Europe for the BNT162 vaccine program to prevent COVID-19 in collaboration with German mRNA company BioNTech.

The BNT162 vaccine is now being tested on humans after getting the necessary clinical approvals.

Apart from this, AstraZeneca is in partnership with the University of Oxford to develop a vaccine based on a weakened strained of adenovirus. They have combined Adenovirus, which causes the common cold in chimpanzees, with the genetic material of the novel coronavirus.

Currently, Moderna Inc. is also leading the race of developing a potential vaccine for COVID-19. The company’s mRNA vaccine has successfully finished its phase 1 clinical trials as the outcomes are producing protective antibodies against the virus. They are all set to begin phase 2 of its clinical trials on 600 healthy individuals.